Target intelligence / Profile preview

Cytochrome c (CYCS) (CYCS)

Target
CYCS
Molecular classification
Heme protein, Electron carrier, Oxidoreductase
01

Overview

Cytochrome c is a highly conserved small heme protein (approximately 12 kDa) primarily located in the mitochondrial intermembrane space, where it serves as an essential component of the electron transport chain (UniProt: P99999). It functions as a mobile electron carrier, transferring electrons from cytochrome bc1 complex (Complex III) to cytochrome c oxidase (Complex IV), a process vital for ATP synthesis via oxidative phosphorylation (NCBI Gene: 54205). Beyond its bioenergetic role, cytochrome c is a central trigger for the intrinsic pathway of apoptosis; its translocation from the mitochondria to the cytosol leads to the formation of the apoptosome and the activation of the caspase cascade (PubMed: 8887625). In clinical contexts, mutations in the CYCS gene are associated with thrombocytopenia 4, while its dysregulation is a hallmark of cancer and neurodegeneration (StatPearls: NBK554417). Pharmacological modulation of cytochrome c often involves stabilizing its interaction with cardiolipin to preserve mitochondrial integrity, as seen with the investigational drug elamipretide, or inducing its release to promote cell death in oncology (DrugBank: DB12250). Additionally, the release of cytochrome c into the systemic circulation serves as a clinical biomarker for cellular injury and mitochondrial distress in conditions such as myocardial infarction and liver failure (PubMed: 15155835).

Other names
CYCHCSTHC4Cytochrome c, somatic
02

Mechanism of action

Stabilization of mitochondrial membrane association or induction of cytosolic release to trigger the apoptosome.

03

Biological functions

Electron transport chainApoptosisOxidative phosphorylationRedox signaling
04

Disease associations

CancerThrombocytopeniaNeurodegenerative diseaseIschemia-reperfusion injury
05

Safety considerations

Mitochondrial toxicityOff-target apoptosis induction
06

Interacting drugs

Elamipretide

3 more in the full profile.

07

Biomarkers

Serum cytochrome cCytosolic cytochrome c levels

Beyond the preview

Go deeper on Cytochrome c (CYCS) (CYCS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c (CYCS) (CYCS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call